| Breakdown | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 513.42B | 483.99B | 455.09B | 430.30B | 407.04B |
| Gross Profit | 146.97B | 144.04B | 119.39B | 121.64B | 121.96B |
| EBITDA | 52.80B | 51.84B | 36.61B | 41.68B | 43.51B |
| Net Income | 30.51B | 21.42B | 13.17B | 16.03B | 18.01B |
Balance Sheet | |||||
| Total Assets | 480.53B | 462.37B | 426.01B | 403.38B | 381.00B |
| Cash, Cash Equivalents and Short-Term Investments | 80.60B | 88.14B | 68.61B | 67.83B | 68.34B |
| Total Debt | 25.26B | 22.42B | 31.79B | 32.47B | 41.73B |
| Total Liabilities | 132.93B | 130.73B | 114.70B | 108.76B | 111.70B |
| Stockholders Equity | 324.06B | 302.29B | 281.88B | 267.66B | 245.64B |
Cash Flow | |||||
| Free Cash Flow | 16.21B | 45.00B | 8.56B | 14.72B | 30.79B |
| Operating Cash Flow | 31.80B | 63.13B | 23.73B | 27.20B | 38.53B |
| Investing Cash Flow | -16.91B | -23.89B | -16.68B | -15.95B | -20.28B |
| Financing Cash Flow | -30.10B | -21.13B | -10.56B | -16.81B | -18.70B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥1.47T | 18.60 | 11.19% | 1.46% | 2.65% | -5.76% | |
72 Outperform | ¥491.90B | 15.17 | 9.86% | 2.58% | 1.08% | 2.71% | |
72 Outperform | ¥36.95B | 6.02 | ― | 2.23% | -0.25% | -41.09% | |
71 Outperform | ¥539.34B | 28.74 | 9.28% | 1.30% | 5.50% | 27.32% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | ¥1.07T | 13.62 | 5.97% | 2.96% | 2.79% | -6.46% | |
61 Neutral | ¥4.52T | 20.92 | 9.46% | 1.32% | 1.99% | -18.79% |